Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2018 3
2019 5
2020 12
2021 18
2022 13
2023 9
2024 21
2025 9

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

78 results

Results by year

Filters applied: . Clear all
Page 1
Blood-based biomarkers for Alzheimer's disease: towards clinical implementation.
Teunissen CE, Verberk IMW, Thijssen EH, Vermunt L, Hansson O, Zetterberg H, van der Flier WM, Mielke MM, Del Campo M. Teunissen CE, et al. Among authors: verberk imw. Lancet Neurol. 2022 Jan;21(1):66-77. doi: 10.1016/S1474-4422(21)00361-6. Epub 2021 Nov 24. Lancet Neurol. 2022. PMID: 34838239 Review.
Biomarker-based staging of Alzheimer disease: rationale and clinical applications.
Therriault J, Schindler SE, Salvadó G, Pascoal TA, Benedet AL, Ashton NJ, Karikari TK, Apostolova L, Murray ME, Verberk I, Vogel JW, La Joie R, Gauthier S, Teunissen C, Rabinovici GD, Zetterberg H, Bateman RJ, Scheltens P, Blennow K, Sperling R, Hansson O, Jack CR Jr, Rosa-Neto P. Therriault J, et al. Among authors: verberk i. Nat Rev Neurol. 2024 Apr;20(4):232-244. doi: 10.1038/s41582-024-00942-2. Epub 2024 Mar 1. Nat Rev Neurol. 2024. PMID: 38429551 Review.
Head-to-Head Comparison of 8 Plasma Amyloid-β 42/40 Assays in Alzheimer Disease.
Janelidze S, Teunissen CE, Zetterberg H, Allué JA, Sarasa L, Eichenlaub U, Bittner T, Ovod V, Verberk IMW, Toba K, Nakamura A, Bateman RJ, Blennow K, Hansson O. Janelidze S, et al. Among authors: verberk imw. JAMA Neurol. 2021 Nov 1;78(11):1375-1382. doi: 10.1001/jamaneurol.2021.3180. JAMA Neurol. 2021. PMID: 34542571 Free PMC article.
Adaptive immune changes associate with clinical progression of Alzheimer's disease.
van Olst L, Kamermans A, Halters S, van der Pol SMA, Rodriguez E, Verberk IMW, Verberk SGS, Wessels DWR, Rodriguez-Mogeda C, Verhoeff J, Wouters D, Van den Bossche J, Garcia-Vallejo JJ, Lemstra AW, Witte ME, van der Flier WM, Teunissen CE, de Vries HE. van Olst L, et al. Among authors: verberk imw. Mol Neurodegener. 2024 Apr 24;19(1):38. doi: 10.1186/s13024-024-00726-8. Mol Neurodegener. 2024. PMID: 38658964 Free PMC article.
CSF proteins of inflammation, proteolysis and lipid transport define preclinical AD and progression to AD dementia in cognitively unimpaired individuals.
Del Campo M, Quesada C, Vermunt L, Peeters CFW, Hok-A-Hin YS, Trieu C, Braber AD, Verberk IMW, Visser PJ, Tijms BM, van der Flier WM, Teunissen CE. Del Campo M, et al. Among authors: verberk imw. Mol Neurodegener. 2024 Nov 11;19(1):82. doi: 10.1186/s13024-024-00767-z. Mol Neurodegener. 2024. PMID: 39523360 Free PMC article.
Performance of plasma p-tau217 and NfL in an unselected memory clinic setting.
Rousset RZ, Claessen T, van Harten AC, Lemstra AW, Pijnenburg YAL, van der Flier WM, den Braber A, Jeromin A, Verberk IMW, Teunissen CE. Rousset RZ, et al. Among authors: verberk imw. Alzheimers Dement (Amst). 2024 Nov 23;16(4):e70003. doi: 10.1002/dad2.70003. eCollection 2024 Oct-Dec. Alzheimers Dement (Amst). 2024. PMID: 39583647 Free PMC article.
Development of thresholds and a visualization tool for use of a blood test in routine clinical dementia practice.
Verberk IMW, Jutte J, Kingma MY, Vigneswaran S, Gouda MMTEE, van Engelen MP, Alcolea D, Arranz J, Fortea J, Lleó A, Chevalier C, Marizzoni M, van de Giessen EM, Lemstra AW, Pijnenburg YAL, van der Flier WM, den Braber A, Wilson D, Schut MC, van Harten AC, Teunissen CE. Verberk IMW, et al. Alzheimers Dement. 2024 Sep;20(9):6115-6132. doi: 10.1002/alz.14088. Epub 2024 Aug 3. Alzheimers Dement. 2024. PMID: 39096164 Free PMC article.
Rationale and design of the BeyeOMARKER study: prospective evaluation of blood- and eye-based biomarkers for early detection of Alzheimer's disease pathology in the eye clinic.
Bader I, Groot C, Tan HS, Milongo JA, Haan JD, Verberk IMW, Yong K, Orellina J, Campbell S, Wilson D, van Harten AC, Kok PHB, van der Flier WM, Pijnenburg YAL, Barkhof F, van de Giessen E, Teunissen CE, Bouwman FH, Ossenkoppele R. Bader I, et al. Among authors: verberk imw. Alzheimers Res Ther. 2024 Aug 21;16(1):190. doi: 10.1186/s13195-024-01545-1. Alzheimers Res Ther. 2024. PMID: 39169442 Free PMC article.
78 results